Angus C Nairn did his undergraduate training in biochemistry at the University of Edinburgh, Scotland, and his Ph.D. in muscle biochemistry at Birmingham University, England. He then carried out postdoctoral research in molecular neuroscience at Yale University and moved to Rockefeller University in 1983 as a faculty member. He moved back to Yale University in 2001, where he is currently the Charles B.G. Murphy Professor of Psychiatry. He also holds a joint appointment in the Department of Pharmacology. He is co-director of the Yale/National Institute of Drug Abuse Neuroproteomics Center at the Yale School of Medicine.
Research Keywords & Expertise
Protein Kinases
Psychiatry
Schizophrenia
Signal Transduction
Parkinson disease
Dopamine
Huntington disease
Fingerprints
38%
Protein Kinases
15%
Dopamine
6%
Signal Transduction
5%
Schizophrenia
5%
Parkinson disease
5%
Huntington disease
Short Biography
Angus C Nairn did his undergraduate training in biochemistry at the University of Edinburgh, Scotland, and his Ph.D. in muscle biochemistry at Birmingham University, England. He then carried out postdoctoral research in molecular neuroscience at Yale University and moved to Rockefeller University in 1983 as a faculty member. He moved back to Yale University in 2001, where he is currently the Charles B.G. Murphy Professor of Psychiatry. He also holds a joint appointment in the Department of Pharmacology. He is co-director of the Yale/National Institute of Drug Abuse Neuroproteomics Center at the Yale School of Medicine.